title: Repaglinide induced acute hepototoxicity.
abstract: Repaglinide is considered a safe drug; adverse events are mild to moderate which includes hypoglycemia, headache, nausea, vomiting, diarrhea and dyspepsia as similar to sulphonylureas. This case report describes a rare side effect of repaglinide. In rare cases, elevated liver enzymes have been noted. We report a case of acute hepatotoxicity in a 78-year-old woman who developed acute hepatotoxicity while taking repaglinide.
authors.affiliation: Department of Medicine, Mercy Catholic Medical Center, Drexel University College of Medicine, Philadelphia, USA. sjkalu@gmail.com
authors.forename: S
authors.initials: S
authors.lastname: Jaiswal
authors.forename: R
authors.initials: R
authors.lastname: Mehta
authors.forename: M
authors.initials: M
authors.lastname: Musuku
authors.forename: L
authors.initials: L
authors.lastname: Tran
authors.forename: W
authors.initials: W
authors.lastname: McNamee
mesh_terms: D000208:Acute Disease; D000368:Aged; D002219:Carbamates / Q000008:administration & dosage / Q000009:adverse effects*; D056486:Chemical and Drug Induced Liver Injury / Q000175:diagnosis / Q000209:etiology*; D049448:Cholangiopancreatography, Magnetic Resonance; D003924:Diabetes Mellitus, Type 2 / Q000188:drug therapy*; D003937:Diagnosis, Differential; D005260:Female; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage / Q000009:adverse effects*; D010880:Piperidines / Q000008:administration & dosage / Q000009:adverse effects*
chemical_list: D002219:Carbamates; D007004:Hypoglycemic Agents; D010880:Piperidines; C072379:repaglinide